Connection
Vivian Shi to Injections, Subcutaneous
This is a "connection" page, showing publications Vivian Shi has written about Injections, Subcutaneous.
|
|
Connection Strength |
|
|
|
|
|
0.387 |
|
|
|
-
Shi VY, Bhutani T, Fonacier L, Deleuran M, Shumack S, Valdez H, Zhang F, Chan GL, Cameron MC, Yin NC. Phase 3 efficacy and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis after switching from dupilumab (JADE EXTEND). J Am Acad Dermatol. 2022 08; 87(2):351-358.
Score: 0.212
-
Hendricks AJ, Lio PA, Shi VY. Management Recommendations for Dupilumab Partial and Non-durable Responders in Atopic Dermatitis. Am J Clin Dermatol. 2019 Aug; 20(4):565-569.
Score: 0.175